News
The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...
Ori Biotech’s CEO said the prioritization of review by FDA, coupled to the impact of the technology, could shave up to three ...
Hosted on MSN
A 19-year-old won $100,000 for inventing a cheaper, faster way to make antiviral drugs out of corn husks
When Adam Kovalčík flew to Ohio for an international science competition, he did not expect to come home with $100,000. The 19-year-old from Dulovce, Slovakia won that sum on Friday, though, because ...
Pharmaceutical giant Eli Lilly will construct a state-of-the-art manufacturing facility in Goochland County as part of a ...
Process validation is crucial for ensuring the quality of final products and the safety of these processes for manufacturing personnel and consumers in the pharmaceutical, medical device, and ...
The Catalysis Research Team led by UMaine professor Tom Schwartz has been working over the past few years to develop the chemical process.
In Breaking Bad, the portrayal of meth production equipment is eerily accurate. The show portrays realistic setups, with a ...
This spring, the Trump administration renewed calls to bring drug manufacturing and production back to American shores, reigniting debate about what it will take to move onshoring from a lofty dream ...
It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...
Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results